February 18, 2011
A new jointly funded program has recently been established between NIH and the National Natural Science Foundation of China (NSFC) to encourage research cooperation between U.S. and Chinese scientists. The intent of this initiative is to foster, stimulate, and/or expand collaborative basic, translational, and applied research cooperation between eligible NIH grantees and eligible Chinese researchers in the areas of cancer, allergy, immunology, and infectious diseases including HIV/AIDS and its co-morbidities.
The NIH announcement is a notice of availability for administrative supplements where the U.S. collaborating investigator has an active R01, P01, U01, U1, U54, P30 (as pilot projects to the Developmental Core with no additional funding to infrastructure), or P50 grant with at least one year of active funding remaining at the time of the administrative supplement award on September 30, 2011. (see http://grants.nih.gov/grants/guide/notice-files/NOT-CA-11-003.html for more information.) The corresponding NSFC announcement will support new, one-year projects. Chinese collaborating investigators who are current or former NSFC grantees are eligible to apply (see http://www.nsfc.gov.cn/Portal0/InfoModule_396/31674.htm for more information). Please note that a U.S. application to the NIH and a corresponding Chinese application to the NSFC must be submitted to be considered for funding.
Questions about this program can be directed to:
Julie A. Schneider, Ph.D.
Program Director, Office of China Cancer Programs
National Cancer Institute, National Institutes of Health
Based at the U.S. Embassy, Beijing